| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.42 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |